Benefit of Latanoprostene Bunod (Vyzulta) for Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Cohort Study in Taiwan

Abstract Introduction Topical prostaglandin analogs (PGAs) are used to treat glaucoma and provide significant reductions in intraocular pressure (IOP). This study evaluated the efficacy and safety of latanoprostene bunod 0.024% (LBN; Vyzulta®) in Taiwanese patients with glaucoma who were switched fr...

全面介紹

書目詳細資料

Principais autores:	Chen-Jui Chiu, Ying-Ying Chen, Yi-Shan Chen
格式:	Artigo
語言:	Inglês
出版:	Adis, Springer Healthcare 2026-04-01
叢編:	Ophthalmology and Therapy
主題:	Latanoprostene bunod (LBN) Vyzulta Glaucoma Intraocular pressure (IOP) Prostaglandin (PG)
在線閱讀:	https://doi.org/10.1007/s40123-026-01367-4
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!